Reblozyl (Luspatercept–aamt)
- Medicine Name: Reblozyl
- Generic Name: luspatercept–aamt
- Dosage Form & Strength: For injection: 25mg/75mg lyophilized powder in a single-dose vial for reconstitution
- Manufactured By: Celgene Corporation
Reblozyl is an erythroid maturation agent used for the treatment of:
- Anemia in adults with beta (β) thalassemia who require regular red blood cell (RBC) transfusions.
- Anemia failing an erythropoiesis stimulating agent and requiring two or more RBC units over 8 weeks in adults with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
- Assess and review hemoglobin results before each administration of luspatercept-aamt injection. In case an Red Blood Cell transfusion occurred before dosing, consider the pretransfusion hemoglobin for dose evaluation.
- In adult patients with beta thalassemia, TEE or thromboembolic events were reported in Reblozyl-treated patients. Monitor patients with Reblozyl for signs/symptoms of thromboembolic events and institute treatment promptly.
- Hypertension was noted in Reblozyl-treated patients. Blood pressure should be monitored before each administration. Manage new-onset hypertension or exacerbations of preexisting hypertension with the help of anti-hypertensive agents.
- Findings from the animal reproductive studies suggest that Reblozyl 75 mg injection may cause fetal harm if administered to a pregnant woman. Females of reproductive potential should use an effective method of contraception during therapy and for at least three months after the final dose.
What documents are required to import REBLOZYL to India?
REBLOZYL (luspatercept-aamt) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity Proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is REBLOZYL available in India?
REBLOZYL (luspatercept-aamt injections) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
On availability of Reblozyl 25 mg injection in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
REBLOZYL can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of REBLOZYL (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for Reblozyl injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the REBLOZYL (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Reblozyl®?
Luspatercept–aamt is Generic Name for the trade name drug Reblozyl®.
What is the Manufacturer Name of Reblozyl®?
Reblozyl® is manufactured by Celgene Corporation.
Is Reblozyl® approved by the FDA?
Yes, Reblozyl® is approved by the FDA. Date of approval: November 8, 2019.
What is the dosage and form of Reblozyl® supplied?
Reblozyl® is supplied for injection: 25 mg and 75 mg lyophilized powder in a single-dose vial for reconstitution for subcutaneous administration.
What are the most common side effects due to Reblozyl®?
Most common side effects due to Reblozyl® include: cough, fatigue, headache, arthralgia, dizziness/vertigo, musculoskeletal pain, nausea, diarrhea, abdominal pain, dyspnea, and hypersensitivity
How much does Reblozyl® cost in India?
Reblozyl injection cost in India is reasonably less and can vary. In order to procure this erythroid maturation agent authentically, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Reblozyl®?
Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton in order to protect from the light. Do not freeze.
Is it safe to buy Reblozyl® online in India?
Yes, You can buy Reblozyl online in India legitimately from https://www.indianpharmanetwork.in/ if this medication has not been approved or is not available in your country.
Is Indian Pharma Network certified by WHO-GDP and ISO 9001:2008 authorities?
Yes, We have certification from the highest authorities like WHO-GDP and ISO 9001:2008. Also, we’re the leading Supplier and Wholesaler of Reblozyl in India. We can help you to get this medicinal product at the lowest affordable cost.
What are the Highlights of prescribing information for Reblozyl®?
Click Here to download full Reblozyl prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.